Item Type | Name |
Concept
|
Combined Modality Therapy
|
Academic Article
|
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
|
Academic Article
|
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
|
Academic Article
|
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
|
Academic Article
|
Head and neck cancer.
|
Academic Article
|
Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
|
Academic Article
|
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience.
|
Academic Article
|
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
|
Academic Article
|
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
|
Academic Article
|
Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors.
|
Academic Article
|
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
|
Academic Article
|
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
|
Academic Article
|
The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines.
|
Academic Article
|
Increased injection number enhances adenoviral genetic radiotherapy.
|
Academic Article
|
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.
|
Academic Article
|
Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
|
Academic Article
|
Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation.
|
Academic Article
|
Radiogenetic therapy: on the interaction of viral therapy and ionizing radiation for improving local control of tumors.
|
Academic Article
|
Combined effects of angiostatin and ionizing radiation in antitumour therapy.
|
Academic Article
|
Strategies for enhancing viral-based gene therapy using ionizing radiation.
|
Academic Article
|
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
|
Academic Article
|
Radiation oncology and the new biology.
|
Academic Article
|
Role of gene therapy in radiation oncology.
|
Academic Article
|
Nasopharyngeal carcinoma.
|
Academic Article
|
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.
|
Academic Article
|
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
|
Academic Article
|
Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors.
|
Academic Article
|
Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.
|
Academic Article
|
Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
|
Academic Article
|
Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation.
|
Academic Article
|
Molecular targeting of gene therapy and radiotherapy.
|
Academic Article
|
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
|
Academic Article
|
5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
|
Academic Article
|
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
|
Academic Article
|
Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation.
|
Academic Article
|
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.
|
Academic Article
|
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.
|
Academic Article
|
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
|
Academic Article
|
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
|
Academic Article
|
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.
|
Academic Article
|
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma.
|
Academic Article
|
Palliative radiotherapy.
|
Academic Article
|
Chemotherapeutic and biologic radiation enhancement.
|
Academic Article
|
Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
|
Academic Article
|
Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.
|
Academic Article
|
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
|
Academic Article
|
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.
|
Academic Article
|
Radiotherapy with concomitant chemotherapy for head and neck cancer.
|
Academic Article
|
Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
|
Academic Article
|
Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).
|
Academic Article
|
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
|
Academic Article
|
Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay.
|
Academic Article
|
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
|
Academic Article
|
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.
|
Academic Article
|
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
|
Academic Article
|
Radiation or surgery for chemodectoma of the temporal bone: a review of local control and complications.
|
Academic Article
|
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.
|
Academic Article
|
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
|
Academic Article
|
Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy.
|
Academic Article
|
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
|
Academic Article
|
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
|
Academic Article
|
Recent advances in radiation therapy for head and neck cancer.
|
Academic Article
|
More on cetuximab in head and neck cancer.
|
Academic Article
|
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.
|
Academic Article
|
A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.
|
Academic Article
|
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.
|
Academic Article
|
Chemo-inducible gene therapy.
|
Academic Article
|
Importance of local control in an era of systemic therapy.
|
Academic Article
|
Characterization of response to radiation mediated gene therapy by means of multimodality imaging.
|
Academic Article
|
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
|
Academic Article
|
How does antiangiogenic therapy affect brain tumor response to radiation?
|
Academic Article
|
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.
|
Academic Article
|
Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.
|
Academic Article
|
Breast conserving surgery and definitive irradiation for early stage breast cancer.
|
Academic Article
|
Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors.
|
Academic Article
|
A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer.
|
Academic Article
|
Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1.
|
Academic Article
|
Radiation therapy in the treatment of cervical cancer: the University of Chicago/Michael Reese Hospital experience.
|
Academic Article
|
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
|
Academic Article
|
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy.
|
Academic Article
|
Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas.
|
Academic Article
|
Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results.
|
Academic Article
|
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck.
|
Academic Article
|
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
|
Academic Article
|
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
|
Academic Article
|
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
|
Academic Article
|
Multidisciplinary treatment of advanced squamous carcinoma of the head and neck.
|
Academic Article
|
Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy.
|
Academic Article
|
The role of radiotherapy in locally advanced pancreatic carcinoma.
|
Academic Article
|
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.
|
Academic Article
|
Management of stage I and II Hodgkin's disease.
|
Academic Article
|
Substaging of stage III Hodgkin's disease.
|
Academic Article
|
Treatment selection in T1 and T2 vocal cord carcinoma.
|
Academic Article
|
Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck.
|
Academic Article
|
Treatment of perineural metastasis from squamous carcinoma of the skin with aggressive combination chemotherapy and irradiation.
|
Academic Article
|
Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.
|
Academic Article
|
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
|
Academic Article
|
Improved survival time trends for glioblastoma using the SEER 17 population-based registries.
|
Academic Article
|
Measurable impact: multimodality therapy of head and neck cancer.
|
Academic Article
|
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
|
Academic Article
|
Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.
|
Academic Article
|
Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response.
|
Academic Article
|
Surgical management of the head and neck cancer patient following concomitant multimodality therapy.
|
Academic Article
|
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate.
|
Academic Article
|
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.
|
Academic Article
|
Timing and sequencing of chemoradiotherapy.
|
Academic Article
|
Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience.
|
Academic Article
|
Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine.
|
Academic Article
|
Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role.
|
Academic Article
|
Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide.
|
Academic Article
|
Combined modality therapy of head and neck cancer.
|
Academic Article
|
Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer.
|
Academic Article
|
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus.
|
Academic Article
|
Antitumor interaction of short-course endostatin and ionizing radiation.
|
Academic Article
|
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
|
Academic Article
|
Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications.
|
Academic Article
|
Outcomes in black patients with early breast cancer treated with breast conservation therapy.
|
Academic Article
|
Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.
|
Academic Article
|
Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer.
|
Academic Article
|
The role of post-operative radiation therapy in the treatment of malignant tumors of the parotid gland.
|
Academic Article
|
Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.
|
Academic Article
|
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
|
Academic Article
|
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
|
Academic Article
|
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy.
|
Academic Article
|
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
|
Academic Article
|
Race and competing mortality in advanced head and neck cancer.
|
Academic Article
|
Effect of postradiotherapy neck dissection on nonregional disease sites.
|
Academic Article
|
Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
|
Academic Article
|
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.
|
Academic Article
|
Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.
|
Academic Article
|
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy.
|
Academic Article
|
Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.
|
Academic Article
|
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
|
Academic Article
|
Radiotherapy and immunotherapy: a beneficial liaison?
|
Academic Article
|
Survival outcomes for postoperative chemoradiation in intermediate-risk oral tongue cancers.
|
Academic Article
|
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma.
|
Academic Article
|
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.
|
Academic Article
|
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy.
|
Academic Article
|
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
|
Academic Article
|
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
|
Academic Article
|
Beyond Palliation: The Rationale for Metastasis-Directed Therapy for Metastatic Non-Small Cell Lung Cancer.
|
Academic Article
|
Integration of radiotherapy and immunotherapy for treatment of oligometastases.
|
Academic Article
|
Tumor-reprogrammed resident T cells resist radiation to control tumors.
|
Academic Article
|
Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy.
|
Academic Article
|
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future Focus.
|
Academic Article
|
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
|
Academic Article
|
Prospective Clinical Investigation of the Efficacy of Combination Radiation Therapy With Immune Checkpoint Inhibition.
|
Academic Article
|
Radiotherapy and immunotherapy: open questions and future strategies.
|
Academic Article
|
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
|
Academic Article
|
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal.
|